Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rockwell Medical Technologies (RMTI)
NASDAQ:RMTI
Holding RMTI?
Track your performance easily
RMTI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.16 - $5.15
Previous Close$2.14
Volume547.72K
Average Volume (3M)786.60K
Market Cap
$69.16M
Enterprise Value$65.07M
Total Cash (Recent Filing)$18.27M
Total Debt (Recent Filing)$14.18M
Price to Earnings (P/E)―
Beta3.75
Next Earnings
Mar 13, 2025EPS Estimate
<$0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding32,318,806
10 Day Avg. Volume602,381
30 Day Avg. Volume786,599
Standard Deviation0.24
R-Squared0.09
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)2.31
Price to Sales (P/S)0.70
Price to Cash Flow (P/CF)4.10
P/FCF Ratio4.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.66
Enterprise Value/Gross Profit7.48
Enterprise Value/Ebitda15.03
Forecast
1Y Price Target
$6.00Price Target Upside188.46% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Rockwell Med News
PremiumCompany Announcements
Rockwell Med Appoints New CFO to Strengthen Leadership
Bulls Say, Bears Say
Bulls Say
Market ExpansionThe company remains committed to expansion in the Western U.S. and sees a potential $100M annual incremental revenue opportunity there based on the fact that historically the company has not had a significant presence in this territory.
Product InnovationThe company's introduction of its home dialysis convenience pack underscores RMTI's focus on the rapidly expanding segment of the dialysis market, presenting a significant growth opportunity.
Strategic PartnershipsSeveral key developments this quarter, including a global distribution deal with Nipro Medical Corporation and a product purchase agreement with a leading U.S. at-home and acute dialysis manufacturer, are positives for RMTI.
Bears Say
Customer DiversificationThe largest customer expects future volumes to decline due to supplier diversification.
Earnings EstimatesThe projected loss of product volumes from its key customer has impacted forward estimates.
Stock Price TargetThe 12-month price target is being lowered to $7 from the prior $9 per share due to recent developments.
---
Ownership Overview
2.70% Insiders
4.68% Mutual Funds
16.93% Other Institutional Investors
71.79% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
RMTI FAQ
What was Rockwell Medical Technologies’s price range in the past 12 months?
Rockwell Medical Technologies lowest stock price was $1.16 and its highest was $5.15 in the past 12 months.
What is Rockwell Medical Technologies’s market cap?
Currently, no data Available
When is Rockwell Medical Technologies’s upcoming earnings report date?
Rockwell Medical Technologies’s upcoming earnings report date is Mar 13, 2025 which is in 82 days.
How were Rockwell Medical Technologies’s earnings last quarter?
Rockwell Medical Technologies released its earnings results on Nov 12, 2024. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.01 by $0.04.
Is Rockwell Medical Technologies overvalued?
According to Wall Street analysts Rockwell Medical Technologies’s price is currently Undervalued.
Does Rockwell Medical Technologies pay dividends?
Rockwell Medical Technologies does not currently pay dividends.
What is Rockwell Medical Technologies’s EPS estimate?
Rockwell Medical Technologies’s EPS estimate is <$0.01.
How many shares outstanding does Rockwell Medical Technologies have?
Rockwell Medical Technologies has 32,318,806 shares outstanding.
What happened to Rockwell Medical Technologies’s price movement after its last earnings report?
Rockwell Medical Technologies reported an EPS of $0.05 in its last earnings report, beating expectations of $0.01. Following the earnings report the stock price went down -39.14%.
Which hedge fund is a major shareholder of Rockwell Medical Technologies?
Currently, no hedge funds are holding shares in RMTI
---
Rockwell Med Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$6.00 (188.46% Upside)
$6.00 (188.46% Upside)
Blogger Sentiment
Bullish
RMTI Sentiment 100%
Sector Average 72%
Sector Average 72%
Insider Transactions
Sold Shares
Worth $70.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.8%
Last 30 Days ▲ 9.9%
Last 30 Days ▲ 9.9%
Technicals
SMA
Negative
20 days / 200 days
Momentum
21.59%
12-Months-Change
Fundamentals
Return on Equity
-6.03%
Trailing 12-Months
Asset Growth
8.51%
Trailing 12-Months
Company Description
Rockwell Medical Technologies
Rockwell Medical, Inc. engages in targeting end-stage renal disease and chronic kidney disease. Its dialysis products include hemodialysis concentrates, citrapure, dri-sate, safety data sheets,ancillary products, and renal pure. The company was founded by Robert L. Chioini in January 1995 and is headquartered in Wixom, MI.
---
RMTI Earnings Call
Q3 2024
0:00 / 0:00
---
RMTI Stock 12 Month Forecast
Average Price Target
$6.00
▲(188.46% Upside)
Technical Analysis
Aclaris Therapeutics
―
Actinium Pharmaceuticals
―
Clearside Biomedical
―
ESSA Pharma
―
Best Analysts Covering RMTI
1 Year
1 Year Success Rate
5/12 ratings generated profit
1 Year Average Return
+4.95%
reiterated a buy rating 27 days ago
Copying Ram Selvaraju's trades and holding each position for 1 Year would result in 41.67% of your transactions generating a profit, with an average return of +4.95% per trade.
---